108 related articles for article (PubMed ID: 30819787)
1. Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody.
Émond JP; Labriet A; Desjardins S; Rouleau M; Villeneuve L; Hovington H; Brisson H; Lacombe L; Simonyan D; Caron P; Périgny M; Têtu B; Fallon JK; Klein K; Smith PC; Zanger UM; Guillemette C; Lévesque E
Drug Metab Dispos; 2019 May; 47(5):444-452. PubMed ID: 30819787
[TBL] [Abstract][Full Text] [Related]
2. A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
Hu DG; Gardner-Stephen D; Severi G; Gregory PA; Treloar J; Giles GG; English DR; Hopper JL; Tilley WD; Mackenzie PI
Mol Pharmacol; 2010 Oct; 78(4):714-22. PubMed ID: 20628005
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex.
Bhatt DK; Basit A; Zhang H; Gaedigk A; Lee SB; Claw KG; Mehrotra A; Chaudhry AS; Pearce RE; Gaedigk R; Broeckel U; Thornton TA; Nickerson DA; Schuetz EG; Amory JK; Leeder JS; Prasad B
Drug Metab Dispos; 2018 Jun; 46(6):888-896. PubMed ID: 29602798
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions
Kahma H; Filppula AM; Neuvonen M; Tarkiainen EK; Tornio A; Holmberg MT; Itkonen MK; Finel M; Neuvonen PJ; Niemi M; Backman JT
Drug Metab Dispos; 2018 Feb; 46(2):141-150. PubMed ID: 29138287
[TBL] [Abstract][Full Text] [Related]
5. Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.
Zhang H; Basit A; Busch D; Yabut K; Bhatt DK; Drozdzik M; Ostrowski M; Li A; Collins C; Oswald S; Prasad B
Biochem Pharmacol; 2018 Oct; 156():32-42. PubMed ID: 30086285
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes.
Lazarus P; Zheng Y; Runkle EA; Muscat JE; Wiener D
Pharmacogenet Genomics; 2005 Nov; 15(11):769-78. PubMed ID: 16220109
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Metabolism of Diclofenac by Polymorphic UGT2B17 Correlates with its Highly Variable Pharmacokinetics and Safety across Populations.
Ahire D; Heyward S; Prasad B
Clin Pharmacol Ther; 2023 Jul; 114(1):161-172. PubMed ID: 37042794
[TBL] [Abstract][Full Text] [Related]
8. Promiscuity and Quantitative Contribution of UGT2B17 in Drug and Steroid Metabolism Determined by Experimental and Computational Approaches.
Ahire D; Mariasoosai C; Naji-Talakar S; Natesan S; Prasad B
J Chem Inf Model; 2024 Jan; 64(2):483-498. PubMed ID: 38198666
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.
Gruber M; Bellemare J; Hoermann G; Gleiss A; Porpaczy E; Bilban M; Le T; Zehetmayer S; Mannhalter C; Gaiger A; Shehata M; Fleiss K; Skrabs C; Lévesque É; Vanura K; Guillemette C; Jaeger U
Blood; 2013 Feb; 121(7):1175-83. PubMed ID: 23169782
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity.
Gallagher CJ; Balliet RM; Sun D; Chen G; Lazarus P
Drug Metab Dispos; 2010 Dec; 38(12):2204-9. PubMed ID: 20810538
[TBL] [Abstract][Full Text] [Related]
11. The homeodomain Pbx2-Prep1 complex modulates hepatocyte nuclear factor 1alpha-mediated activation of the UDP-glucuronosyltransferase 2B17 gene.
Gregory PA; Mackenzie PI
Mol Pharmacol; 2002 Jul; 62(1):154-61. PubMed ID: 12065766
[TBL] [Abstract][Full Text] [Related]
12. Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.
Schulze JJ; Lorentzon M; Ohlsson C; Lundmark J; Roh HK; Rane A; Ekström L
Pharmacogenet Genomics; 2008 Jun; 18(6):477-85. PubMed ID: 18496127
[TBL] [Abstract][Full Text] [Related]
13. A pharmacogenetic study of vorinostat glucuronidation.
Kang SP; Ramirez J; House L; Zhang W; Mirkov S; Liu W; Haverfield E; Ratain MJ
Pharmacogenet Genomics; 2010 Oct; 20(10):638-41. PubMed ID: 20729791
[TBL] [Abstract][Full Text] [Related]
14. Intergenic Splicing between Four Adjacent
Hu DG; Hulin JA; Wijayakumara DD; McKinnon RA; Mackenzie PI; Meech R
Mol Pharmacol; 2018 Sep; 94(3):938-952. PubMed ID: 29959221
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.
Hu DG; Mackenzie PI
Drug Metab Dispos; 2010 Dec; 38(12):2105-9. PubMed ID: 20736324
[TBL] [Abstract][Full Text] [Related]
16. The nuclear receptor Rev-erbα participates in circadian regulation of Ugt2b enzymes in mice.
Zhang T; Guo L; Yu F; Chen M; Wu B
Biochem Pharmacol; 2019 Mar; 161():89-97. PubMed ID: 30639455
[TBL] [Abstract][Full Text] [Related]
17. Potential Assessment of UGT2B17 Inhibition by Salicylic Acid in Human Supersomes In Vitro.
Salhab H; Naughton DP; Barker J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361561
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
[TBL] [Abstract][Full Text] [Related]
19. Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line.
Lévesque E; Beaulieu M; Guillemette C; Hum DW; Bélanger A
Endocrinology; 1998 May; 139(5):2375-81. PubMed ID: 9564848
[TBL] [Abstract][Full Text] [Related]
20. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
